ID
45433
Beschrijving
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Uterine Cervical Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000628 In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample.
Link
Trefwoorden
Versies (1)
- 29-11-22 29-11-22 - Chiara Middel
Houder van rechten
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Geüploaded op
29 november 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000628 Characterization of a Metastatic Cervical Cancer Using NGS
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Similar models
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
C0242481 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
C1511726 (UMLS CUI [1,4])